Thermo Fisher Scientific
TMO
2,385 hedge funds and large institutions have $196B invested in Thermo Fisher Scientific in 2023 Q1 according to their latest regulatory filings, with 150 funds opening new positions, 872 increasing their positions, 1,023 reducing their positions, and 92 closing their positions.
63% more first-time investments, than exits
New positions opened: 150 | Existing positions closed: 92
11.93% more ownership
Funds ownership: 88.07% → 100% (+12%)
12% more call options, than puts
Call options by funds: $1.48B | Put options by funds: $1.32B
3% more capital invested
Capital invested by funds: $190B → $196B (+$6.46B)
0% more funds holding
Funds holding: 2,375 → 2,385 (+10)
9% less funds holding in top 10
Funds holding in top 10: 235 → 214 (-21)
15% less repeat investments, than reductions
Existing positions increased: 872 | Existing positions reduced: 1,023
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WEG
World Equity Group
Schaumburg,
Illinois
|
+$2.3B |
| 2 |
TCI Fund Management
London,
United Kingdom
|
+$434M |
| 3 |
BlackRock
New York
|
+$357M |
| 4 |
GIM
Generation Investment Management
London,
United Kingdom
|
+$337M |
| 5 |
Jennison Associates
New York
|
+$291M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$690M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$654M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$350M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$332M |
| 5 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$324M |
TMO Hedge Fund Activity: Q1 2023 in Review
2,385 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2023, worth a combined $196B — up 3.4% from $190B a quarter earlier.
Buyers outnumbered sellers: 150 funds opened new TMO positions and 92 closed out — a net gain of 58 holders — while 872 added to existing stakes and 1,023 trimmed.
The largest buyer was World Equity Group, adding an estimated $2.3B. The largest seller was Capital Research Global Investors, cutting an estimated $690M.
- 2,385 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2023, up from 2,375 in Q4 2022.
- Funds reported $196B of Thermo Fisher Scientific stock for Q1 2023, up 3.4% quarter-over-quarter.
- 150 funds opened new Thermo Fisher Scientific positions in Q1 2023 and 92 closed out, a net change of +58 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2023 was World Equity Group, an estimated $2.3B added.
- The largest Thermo Fisher Scientific seller in Q1 2023 was Capital Research Global Investors, an estimated $690M sold.
Based on aggregated 13F filings for Q1 2023.